Amantadine to help recovery after stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 2 study tests whether the medicine amantadine can improve recovery after a recent stroke. It may help some people regain function during early rehabilitation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old
- You had an ischemic or bleeding stroke within the last 24 hours to 3 weeks
- Before this stroke, you were functioning fairly well (modified Rankin Score 2 or less)
- You can do the study activities and tests, including swallowing evaluation results showing it’s safe to take the medicine
- You have a certain stroke severity range on testing (NIH Stroke Scale between 3 and 15)
- Your kidneys work well enough (creatinine clearance at least 60 mL/min)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.
This study tests a daily supplement called NeuroAiD to see if it helps people recover after a mild or moderate stroke. It looks at how well patients feel and function in their daily life during recovery.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This study tests an experimental drug called ALT001 for people who are still recovering from a stroke that happened at least 6 months ago and within the last 5 years. The drug may help improve limb weakness that persists after a stroke.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
This trial tests whether adding anisodine, a medicine that may protect brain cells, helps people recover better after a stroke caused by a blocked large artery in the brain. It is given after a procedure to remove the clot.
Hear when a new Hemorrhagic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.